Amarin Corp Plc (AMRN)

[couldbebetter]

Noone knows for certain when Vascepa revenues for china will begin. 2019 may be a wild guess at this point. Getting a lock on the market in China is a potentially huge deal! Just getting all of the milestone payments may cure AMRN's debt payment problems in those future years. Royalties at the high teens is very reasonable. Should peak sales be around $1 billion AMRN would receive around $170 million, after taxes around $144 million. Put a PE of 10 to that number and you get $1.44 billion or about $5.00 per each fully future diluted share. (I use 285 million for that.) Again, this is just a model but there is some very real potential value there. Regardless of anything else I am certain that $15 million cash upfront we received in February will go a long way to insure we are in business until Reduce-It results come out.